Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

Features
Research Partnerships Set to Boost Clinical Trials

10 Oct 11

In the aftermath of last year’s inconclusive General Election — and the subsequent emergence of the Coalition Government — you’d have been forgiven for thinking that ‘deficit reduction’ was the only buzzword in town.
Max Golby

New Data Inspire Global Experts to Call for Improved Education, Awareness and Support for Head and Neck Cancer Patients

06 Oct 11

Merck Serono, a division of Merck KGaA, Darmstadt Germany, in partnership with the European Head and Neck Society (EHNS), will convene an expert panel of physicians, who will issue a call-to-action that will focus on providing tailored information, advice and better support networks to head and neck cancer patients.
Merck Serono

Working while on holiday-survey results

04 Oct 11

We recently ran a survey to ask people about the work they do when they are on vacation. It makes interesting reading!
Mike Wood

NICE - Analyst and Adviser Opportunities

03 Oct 11

NICE is a world-renowned, independent organisation responsible for providing national recommendations on the use of new and existing medicines and treatments within the NHS, through the Technology Appraisal Programme. The Scientific Advice Programme provides not-for-profit chargeable consulting services to companies who have products in development that may be referred for future evaluation by NICE.
NICE

European Multidisciplinary Cancer Congress (EMCC)

29 Sep 11

New drug formulations, biological agents, combination therapies and the latest pharmaceutical developments designed to improve outcomes in patients with a wide range of cancers were highlighted at EMCC 2001. Here are just a few of the highlights:
Stephen Pinn

UK Leads the Way with Embryonic Stem Cell Trial

26 Sep 11

Science is always at its most exciting when it looks to the far horizons. And the unavoidably controversial yet incredibly promising area of stem cell science provides arguably one of the most apt examples.
Max Golby

The Social Media effect on the Pharmaceutical & Healthcare Industry

20 Sep 11

Social media has probably become one of the most important forms of communication and interaction to date, and it is here to stay.
Burton Paul

America’s Pill Paucity

07 Sep 11

There’s a drugs shortage in America. That the construction of such a sentence is possible seems baffling for a nation that has led the world in medical innovation for decades.
Max Golby

What's NOT a domain name?

31 Aug 11

Esther Dyson the Great Dame of Silicon Valley, at times matriarch to Bill Gates and many other lads on the innovative circuit, wrote a harsh column August 26th on GPS CNN on ICANN gTLD. I like and respect Esther especially her technical background, we have shared the podium, but as this topic deals with the centrality of global corporate nomenclature it demands an authoritative analysis and I feel it’s my responsibility to clarify and taken the liberty to address her entire piece item by item.
Naseem Javed

Working while on Holiday?

25 Aug 11

How common is it to work during your vacation? - Take our short survey.
Mike Wood

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.